U.S. officials activated Title 42 to block entry from the Democratic Republic of Congo, Uganda and South Sudan after a WHO alert on Ebola. The 30‑day restriction excludes U.S. citizens and service members but bars travelers who visited the three countries in the past 21 days.

CDC cited over 330 suspected cases and nearly 90 deaths in Congo, with two confirmed in Uganda, to justify the order. The move follows the Trump administration’s historic use of the public‑health law to curb migration during the coronavirus pandemic, a tactic that courts and health officials have challenged recently.

Business groups worry the restriction could ripple through airlines, cargo operators and travel agencies that rely on African routes. Investors eye the policy’s impact on market liquidity and expect airlines to report lower passenger revenues during the ban, potentially affecting quarterly earnings for shareholders in 2026 and analysts note significant.

While the order grants the administration broad authority, it also invites legal scrutiny and diplomatic backlash from affected nations. The CDC will review the measure after 30 days, weighing public‑health risks against economic costs and the broader implications for U.S. trade and travel policy in 2026 and watch the outcome.